| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | Australia | 5 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | Brazil | 4 | |
| #5 | Canada | 4 | |
| #6 | China | 4 | |
| #7 | Russian Federation | 3 | |
| #8 | Taiwan | 3 | |
| #9 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Miyakawa Tomoya | 33 |
| #2 | Tamada Koji | 33 |
| #3 | Hazama Shoichi | 18 |
| #4 | Udaka Keiko | 18 |
| #5 | Oka Masaaki | 18 |
| #6 | Doi Shun | 15 |
| #7 | Tomoya Miyakawa | 4 |
| #8 | Koji Tamada | 4 |
| #9 | Masaaki Oka | 2 |
| #10 | Shun Doi | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CN109982711A | Drug | |
| CA2981468A1 | Medicine | |
| BR112017018703A2 | peptide derived from gpc3, pharmaceutical composition for treating or preventing cancer using the same, inducing immunity, and method for producing antigen presenting cells | |
| EP3205661A1 | Hsp70-derived peptide, and method of manufacturing pharmaceutical composition, immunity inducer, and antigen-presenting cell for cancer treatment or prevention using the same |